(0.12%) 5 303.27 points
(0.34%) 40 004 points
(-0.07%) 16 686 points
(0.97%) $80.00
(5.73%) $2.64
(1.44%) $2 419.80
(6.36%) $31.78
(2.18%) $1 094.70
(-0.02%) $0.920
(-0.18%) $10.68
(-0.27%) $0.787
(0.19%) $91.05
-3.29% $ 2.35
Live Chart Being Loaded With Signals
Barinthus Biotherapeutics plc, a clinical-stage biopharmaceutical company, engages in developing novel T cell immunotherapeutics to guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer...
Stats | |
---|---|
Volumen de hoy | 375.00 |
Volumen promedio | 23 677.00 |
Capitalización de mercado | 91.54M |
EPS | $0 ( 2024-05-10 ) |
Próxima fecha de ganancias | ( $-0.500 ) 2024-08-08 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | 0 |
ATR14 | $0.0310 (1.32%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-05-10 | Dawes Karen A | Buy | 19 516 | Share Option (Right to Buy) |
2024-05-10 | Scheeren Joseph | Buy | 19 516 | Share Option (Right to Buy) |
2024-05-10 | Phillips Anne M. | Buy | 19 516 | Share Option (Right to Buy) |
2024-05-10 | Hammacher Alex | Buy | 19 516 | Share Option (Right to Buy) |
2024-05-10 | Morgon Pierre A. | Buy | 19 516 | Share Option (Right to Buy) |
INSIDER POWER |
---|
100.00 |
Last 6 transactions |
Buy: 117 096 | Sell: 0 |
Barinthus Biotherapeutics Correlación
10 Correlaciones Más Positivas |
---|
10 Correlaciones Más Negativas |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Barinthus Biotherapeutics Finanzas
Annual | 2023 |
Ingresos: | $805 108 |
Beneficio Bruto: | $802 000 (99.61 %) |
EPS: | $-1.920 |
FY | 2023 |
Ingresos: | $805 108 |
Beneficio Bruto: | $802 000 (99.61 %) |
EPS: | $-1.920 |
FY | 2022 |
Ingresos: | $44.70M |
Beneficio Bruto: | $44.70M (100.00 %) |
EPS: | $0.140 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Barinthus Biotherapeutics
Barinthus Biotherapeutics plc, a clinical-stage biopharmaceutical company, engages in developing novel T cell immunotherapeutics to guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. It is advancing a pipeline of product candidates across a range of therapeutic areas, including VTP-300, an immunotherapeutic candidate designed as a potential component of a functional cure for chronic HBV infection; VTP-200, a non-surgical product candidate for persistent high-risk human papillomavirus (HPV); VTP-1000, an autoimmune candidate designed to utilize the SNAP-TI platform to treat patients with celiac disease; VTP-850, a second-generation immunotherapeutic candidate designed to treat recurrent prostate cancer; and VTP-1100, a preclinical cancer candidate designed to utilize the SNAP-CI platform to treat patients with HPV-related cancer. The company was formerly known as Vaccitech plc and changed its name to Barinthus Biotherapeutics plc in November 2023. Barinthus Biotherapeutics plc was founded in 2016 and is headquartered in Harwell, the United Kingdom.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico